SINGAPORE, Aug 13, 2025 - (ACN Newswire) - SGX Catalist-listed AsiaMedic Limited (the "Company" and, together with its subsidiaries, the "Group") announced its unaudited financial results for the six months ended 30 June 2025 ("1H2025"), delivering 26% year-on-year revenue growth to S$16.6 million, up from S$13.2 million in 1H2024.
This performance was led by the Group's diagnostic imaging business, which contributed over 60% of total revenue, supported by strong demand at its flagship Shaw Centre clinic and contributions from the newly opened Novena imaging centre.
Financial Highlights:
- Revenue up 26% to S$16.6 million, from S$13.2m in 1H2024, driven by strong growth in diagnostic imaging and steady performance in medical wellness.
- EBITDA attributable to owners of the Company was maintained at S$1.3 million, reflecting consistent contributions from core businesses, even as the new Novena centre incurred ramp-up losses.
- Net loss attributable to owners of the Company narrows significantly to S$38,603 from S$104,431 in 1H2024.
- Cash and cash equivalents stood at S$4.9 million, with an additional S$3.6 million in financial assets, reflecting strong underlying liquidity despite investments into Novena centre.
Profitability was significantly affected by the new Novena imaging centre as it remains in its ramp-up phase. However, the Group's financial performance reflects solid execution of its core business strategy amidst expansion.
Mr Arifin Kwek, Chief Executive Officer of AsiaMedic Limited, said, "Our performance in the first half of 2025 reflects the continued strength of our diagnostic imaging business. Shaw Centre remained our primary growth engine with sustained patient volumes, while the newly opened Novena Centre, though still ramping up, has already begun contributing. These investments will further position us as a trusted provider of early detection and preventive care in Singapore.
Our health screening and medical wellness segment remained stable, underpinned by the government awarded Grow Well SG programme and steady corporate wellness demand. While the opening of Novena has added to our cost, these are deliberate investments in capacity, technology, and skilled professionals in a key medical geographical location in Singapore, that position us for long term growth.
We will continue to build on this foundation, focusing on scaling our imaging and health screening businesses while ensuring we deliver high quality, patient-centred care. With expanded capacity and prudent cost management, AsiaMedic is well placed to capture growth opportunities in Singapore's healthcare sector."
As Singapore continues to position itself as a regional healthcare hub, AsiaMedic is well-placed to meet growing demand for accessible, high-quality diagnostic and preventive healthcare services. With established centres in Orchard and Novena - two of the country's key medical precincts - the Group is strategically expanding its reach to serve a broader patient base. This geographic presence, supported by ongoing investments in technology, infrastructure, and clinical talent, positions AsiaMedic to play a meaningful role in advancing Singapore's preventive care and early detection agenda.
This media release should be read in conjunction with the financial statements announced on SGXNet.
About AsiaMedic Limited
AsiaMedic Limited together with its subsidiaries ("AsiaMedic" or the "Group") is a leading healthcare provider in Singapore which provides holistic solutions through integrated application of the latest medical technologies to preventand detect early illnesses to achieve positive experiences and clinical outcomes for patients. AsiaMedic is listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (SGX-ST).
The Group is committed to helping clients through practical and personalised solutions delivered with the highestprofessional standards of service and expertise in a timely, safe and consistent manner.
With convenient locations at Orchard and Novena, AsiaMedic is a preferred one-stop centre for:
Diagnostic imaging and radiology services
Medical wellness and health screening services
Primary healthcare services
Medical aesthetic services and products
For more information, please visit www.asiamedic.com.sg
For media and analysts' queries, please contact:
Waterbrooks Consultants
Wayne Koo
T: (65) 9338 8166 / (65) 8901 9780
E: wayne.koo@waterbrooks.com.sg / query@waterbrooks.com.sg
This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd. It has not been examinedor approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 6319 4954.
Source: AsiaMedic Limited
Copyright 2025 ACN Newswire . All rights reserved.
© 2025 JCN Newswire
